Summary
Updated Aug 30, 2026
Dwight H. Egan is Chief Executive Officer of Co-Diagnostics, Inc. (CODX). 4 SEC Form 4 filings on record going back to 2024, most recently on 27 May 2026.
Recent Transactions
6Every recent SEC Form 4 transaction Dwight H. Egan has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Dwight H. Egan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M of HTFL open-market activity in the last 12 months
- Herriot Tabuteau - $110.58M of AXSM open-market activity in the last 12 months
- Mayukh Sukhatme - $109.13M of ROIV open-market activity in the last 12 months
- Michael Simanovsky - $105.88M of SNDA open-market activity in the last 12 months
- Eric Venker - $103.97M of ROIV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Dwight H. Egan?
Dwight H. Egan is a corporate insider, tracked as Chief Executive Officer of Co-Diagnostics, Inc. (CODX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Dwight H. Egan last file a Form 4?
The most recent primary Form 4 on record is dated 27 May 2026, one of 4 filings going back to 2024.
Where can I see all of Dwight H. Egan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Dwight H. Egan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
